EUVIMEDEUVIMED entdecken
Crossref

Nanotechnology Based Delivery System of Nutraceuticals in Cancer

Anshu Jaiswal, Ridhima Singh, Divi Gautam, Pragati Shrivastava

International Journal of Drug Delivery Technology · 04.06.2026 · 16 (46s)

DOI: 10.25258/ijddt.16.46s.72 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 04.06.2026. Verfasst von Anshu Jaiswal und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose: Cancer remains one of the leading causes of mortality worldwide, highlighting the urgent need for safer and more effective therapeutic strategies. Nutraceuticals—bioactive compounds derived from plant or animal sources—have shown strong anticancer potential through mechanisms such as apoptosis induction, inhibition of angiogenesis, and suppression of metastasis. However, their clinical translation is limited by poor water solubility, low gastrointestinal bioavailability, chemical instability, and lack of targeted delivery. This review aims to explore how nanotechnology can overcome these limitations by developing advanced nanodelivery platforms for nutraceutical-based cancer therapy. Principal Results: The review summarizes recent advances in lipid-based nanoparticles, polymeric nanoparticles, and inorganic nanoparticle systems designed to enhance the delivery of key nutraceuticals such as curcumin, resveratrol, and quercetin. These nano-platforms significantly improve therapeutic efficacy, systemic availability, and bio-stability. Strategies including active targeting, stimuli-responsive release, and exploitation of the Enhanced Permeability and Retention (EPR) effect are critically examined. Additionally, recent preclinical and emerging clinical findings demonstrate improved anticancer performance of nano-enabled nutraceutical delivery systems. Major Conclusions: Nanotechnology offers a promising solution to the major challenges associated with nutraceutical application in cancer therapy. Nano-based delivery systems can enhance targeting efficiency, stability, and therapeutic outcomes, thereby accelerating the clinical translation of nutraceuticals. Continued research addressing current challenges and optimizing translational strategies could enable nanotechnologydriven nutraceutical delivery systems to play a transformative role in future cancer treatment.

Zitieren

APA

Jaiswal, A., Singh, R., Gautam, D., & Shrivastava, P. (2026). Nanotechnology Based Delivery System of Nutraceuticals in Cancer. International Journal of Drug Delivery Technology, 16(46s). https://doi.org/10.25258/ijddt.16.46s.72

Vancouver

Jaiswal A, Singh R, Gautam D, Shrivastava P. Nanotechnology Based Delivery System of Nutraceuticals in Cancer. International Journal of Drug Delivery Technology. 2026;16(46s). doi:10.25258/ijddt.16.46s.72

BibTeX
@article{Jaiswal2026,
  author = {Jaiswal, Anshu and Singh, Ridhima and Gautam, Divi and Shrivastava, Pragati},
  title = {Nanotechnology Based Delivery System of Nutraceuticals in Cancer},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {46s},
  doi = {10.25258/ijddt.16.46s.72}
}
Kostenlos starten →